PortfoliosLab logo
AMT vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMT and NVS is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

AMT vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in American Tower Corporation (AMT) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

AMT:

0.50

NVS:

0.45

Sortino Ratio

AMT:

1.06

NVS:

0.79

Omega Ratio

AMT:

1.14

NVS:

1.11

Calmar Ratio

AMT:

0.50

NVS:

0.50

Martin Ratio

AMT:

1.45

NVS:

1.06

Ulcer Index

AMT:

12.53%

NVS:

9.30%

Daily Std Dev

AMT:

27.92%

NVS:

19.94%

Max Drawdown

AMT:

-98.70%

NVS:

-41.72%

Current Drawdown

AMT:

-22.12%

NVS:

-7.05%

Fundamentals

Market Cap

AMT:

$99.10B

NVS:

$210.15B

EPS

AMT:

$6.18

NVS:

$6.38

PE Ratio

AMT:

34.25

NVS:

16.46

PEG Ratio

AMT:

50.79

NVS:

1.25

PS Ratio

AMT:

9.74

NVS:

3.95

PB Ratio

AMT:

27.08

NVS:

5.40

Total Revenue (TTM)

AMT:

$10.53B

NVS:

$52.86B

Gross Profit (TTM)

AMT:

$7.21B

NVS:

$39.86B

EBITDA (TTM)

AMT:

$7.45B

NVS:

$21.88B

Returns By Period

In the year-to-date period, AMT achieves a 16.36% return, which is significantly higher than NVS's 15.47% return. Over the past 10 years, AMT has outperformed NVS with an annualized return of 10.91%, while NVS has yielded a comparatively lower 6.33% annualized return.


AMT

YTD

16.36%

1M

-2.90%

6M

10.55%

1Y

13.89%

5Y*

1.09%

10Y*

10.91%

NVS

YTD

15.47%

1M

-1.34%

6M

8.67%

1Y

8.86%

5Y*

10.85%

10Y*

6.33%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMT vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMT
The Risk-Adjusted Performance Rank of AMT is 6969
Overall Rank
The Sharpe Ratio Rank of AMT is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of AMT is 6767
Sortino Ratio Rank
The Omega Ratio Rank of AMT is 6666
Omega Ratio Rank
The Calmar Ratio Rank of AMT is 7272
Calmar Ratio Rank
The Martin Ratio Rank of AMT is 6868
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 6565
Overall Rank
The Sharpe Ratio Rank of NVS is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 6060
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 5959
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 7272
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 6464
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMT vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for American Tower Corporation (AMT) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current AMT Sharpe Ratio is 0.50, which is comparable to the NVS Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of AMT and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

AMT vs. NVS - Dividend Comparison

AMT's dividend yield for the trailing twelve months is around 3.10%, less than NVS's 3.68% yield.


TTM20242023202220212020201920182017201620152014
AMT
American Tower Corporation
3.10%3.53%2.99%2.77%1.78%2.02%1.64%1.99%1.84%2.05%1.87%1.42%
NVS
Novartis AG
3.68%3.84%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

AMT vs. NVS - Drawdown Comparison

The maximum AMT drawdown since its inception was -98.70%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for AMT and NVS. For additional features, visit the drawdowns tool.


Loading data...

Volatility

AMT vs. NVS - Volatility Comparison

American Tower Corporation (AMT) has a higher volatility of 10.45% compared to Novartis AG (NVS) at 6.86%. This indicates that AMT's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

AMT vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between American Tower Corporation and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
2.56B
13.62B
(AMT) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

AMT vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between American Tower Corporation and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20212022202320242025
75.2%
76.3%
(AMT) Gross Margin
(NVS) Gross Margin
AMT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, American Tower Corporation reported a gross profit of 1.93B and revenue of 2.56B. Therefore, the gross margin over that period was 75.2%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novartis AG reported a gross profit of 10.39B and revenue of 13.62B. Therefore, the gross margin over that period was 76.3%.

AMT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, American Tower Corporation reported an operating income of 1.25B and revenue of 2.56B, resulting in an operating margin of 48.9%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novartis AG reported an operating income of 4.66B and revenue of 13.62B, resulting in an operating margin of 34.2%.

AMT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, American Tower Corporation reported a net income of 488.70M and revenue of 2.56B, resulting in a net margin of 19.1%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novartis AG reported a net income of 3.61B and revenue of 13.62B, resulting in a net margin of 26.5%.